Anebulo Pharmaceuticals's market cap is currently $51.77M. The company's EPS TTM is $-0.29; its P/E ratio is ―; Anebulo Pharmaceuticals is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -8.31M	$ -11.78M	$ -6.83M	$ -3.61M	$ -173.35K
EBITDA	$ -8.05M	$ -11.78M	$ 5.55K	$ -30.24M	$ -173.35K
Net Income	$ -8.20M	$ -11.73M	$ -6.81M	$ -30.26M	$ -174.64K
Balance Sheet
Cash & Short-Term Investments	$ 3.09M	$ 11.25M	$ 14.55M	$ 19.99M	$ 3.02M
Total Assets	$ 4.07M	$ 11.67M	$ 15.58M	$ 21.65M	$ 3.03M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 201.29K
Net Debt	$ -3.09M	$ -11.25M	$ -14.55M	$ -19.99M	$ -2.82M
Total Liabilities	$ 260.58K	$ 1.07M	$ 512.53K	$ 241.63K	$ 3.20M
Stockholders' Equity	$ 3.81M	$ 10.60M	$ 15.07M	$ 21.41M	$ -171.14K
Cash Flow
Free Cash Flow	$ -8.09M	$ -9.68M	$ -5.44M	$ -4.87M	$ -150.77K
Operating Cash Flow	$ -8.09M	$ -9.68M	$ -5.44M	$ -4.87M	$ -150.77K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ -62.35K	$ 6.38M	$ 0.00	$ 21.83M	$ 3.18M

Currency in USD

Anebulo Pharmaceuticals Earnings and Revenue History

Income Statement >

Anebulo Pharmaceuticals Debt to Assets

Balance Sheet >

Anebulo Pharmaceuticals Cash Flow

Cash Flow >

Anebulo Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing